We also identified unique signatures in tumour samples after VV-αCEA TCE treatment, including increased levels of CCL1, IFNγ, IL-1a, IL-1b, TIMP-1, and TREM-1 (Figure 5D, Supplementary Figures 11B–H). The gene discussed is CCL1; the disease is neoplasm.